Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
6 Patents
#49 in Malvern, PA
#1,625 in Pennsylvania
#45,030 in US
Recro Pharma, Inc.
Forward Citations = 20
13 inventors:
Malvern, PA, United States of America
Recro Pharma, Inc.
Calculating rank
% Expired Patents = 66.7
CIPO Patents = 1
EPO Patents = 3
Trademarks = 5
Forward Citations = 20
Loading Chart...
Loading Chart...
13 inventors (with patents filed for the assignee):
Riitta Heino (3 out of 3 patents)
Tiina Leino (3 out of 3 patents)
John Dallas Pruitt (2 out of 70 patents)
4. Eugene Rex Cooper (2 out of 49 patents)
5. Tuula Ryde (2 out of 15 patents)
6. Laura Kline (2 out of 6 patents)
7. Tarja Lehtimaki (2 out of 2 patents)
8. Randall J Mack (1 out of 4 patents)
9. Geraldine A Henwood (1 out of 2 patents)
10. Christopher T Sharr (1 out of 2 patents)
11. Charles Alexander Freyer (1 out of 1 patent)
12. Tarja Lehtimäki (1 out of 1 patent)
13. John Joseph Koleng, Jr (1 out of 27 patents)
14. Geraldine Anne Henwood (0 patent)
15. Randall Jerome Mack (0 patent)
6 patents:
Company Overview
Recro Pharma is a specialty pharmaceutical company focused on developing non-opioid therapeutics for the treatment of acute postoperative pain. The company's lead product candidate, IV meloxicam, is currently in late-stage clinical development and has the potential to provide a safe and effective alternative to opioid-based pain management. Recro Pharma is dedicated to addressing the ongoing opioid crisis by providing innovative solutions for pain management.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Recro Pharma, Inc.. Retrieved from https://idiyas.com/company/recro-pharma
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
1 patent (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
3 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]